Our additional preliminary studies demonstrate that dual targeting of multiple myeloma cells and BM-CAFs by CAR-T cells is ...

It induces a specific type of immunity, called Th17 immunity, that seems to prevent suppression of the immune system. The ...

TOP1 is the target of topotecan, which was approved in 1997 by the U.S. Food and Drug Administration (FDA) to treat relapsed ...

Researchers in the Pancreatic Cancer Early Detection Research Program are using multiple approaches to develop new tools for the early detection of pancreatic cancer, collaborating not only within our ...

Mayo Clinic cares for nearly 1,100 people with pancreatic cancer each year. In addition, the High-Risk Pancreas Clinic offers people at high risk of developing pancreatic cancer an evaluation and ...

CCaTS may grant no-cost extensions to Benefactor-Funded Research Established-Investigator Career Development Awards.

Cardiologists Patricia J M Best, M.D.; Marysia S. Tweet, M.D., M.S.; and Sharonne N. Hayes, M.D., investigate the causes and risk factors for SCAD and are working ...

Many studies that use the Mayo Clinic Biobank are aimed at better understanding how a person's genes (DNA) may influence overall health and wellness. A blood sample and medical information are ...

Our lab is dedicated to improving outcomes for patients with glioblastoma by developing new treatments, overcoming treatment resistance and guiding individualized therapy. The Translational ...

At Mayo Clinic Comprehensive Cancer Center, a culture of innovation and collaboration is driving research breakthroughs that are unraveling the mysteries of cancer as we work toward a cure for ...

Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new ...

The Mayo Clinic Institutional Review Board's definition of terms explains legal definitions related to research guidelines and the protection of human research subjects, including advocate, conflict ...